Xiaodong Wang - 09 Nov 2026 Form 4 Insider Report for BeOne Medicines Ltd. (ONC)

SEC form
4
Accepted by SEC
12 Nov 2026, 16:30:45 UTC
Prior SEC filing
29 Oct 2026
Source filing
View source filing
Filing notes and source

Key filing fact

Xiaodong Wang filed Form 4 for BeOne Medicines Ltd. (ONC) on 12 Nov 2026.

Key facts

  • This page summarizes Xiaodong Wang's Form 4 filing for BeOne Medicines Ltd. (ONC).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 12 Nov 2026, 16:30.

Change

  • Previous filing in this sequence was filed on 29 Oct 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001662982 Primary reporting owner

Wang Xiaodong

Relationship
Director, Chair, Scientific Advisory Brd

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ONC transaction

Ordinary Shares

Gift

Transaction value
Shares
-1,183
Change %
-0.03%
Price
$0.000000*
Shares after
4,586,930
Date
09 Nov 2026
Ownership
Direct
Footnotes
F1
ONC holding

Ordinary Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
1,025,063
Date
09 Nov 2026
Ownership
See Footnote
Footnotes
F2
ONC holding

Ordinary Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
3,953,100
Date
09 Nov 2026
Ownership
See Footnote
Footnotes
F3
ONC holding

Ordinary Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
50
Date
09 Nov 2026
Ownership
See Footnote
Footnotes
F4
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

Bona fide gift(s) of shares which are exempt from Section 16(b) of the Securities Exchange Act pursuant to Rule 16b-5.

Footnote F2

These securities are held by a family trust, the beneficiaries of which are the Reporting Person's family members, for which the Reporting Person disclaims beneficial ownership.

Footnote F3

These securities are held by Wang Investment LLC, of which 99% of the limited liability company interests are owned by two grantor retained annuity trusts, of which the Reporting Person's wife is a trustee, for which the Reporting Person disclaims beneficial ownership.

Footnote F4

These securities are held in a UTMA account for Reporting Person's minor child, for which Reporting Person disclaims beneficial ownership.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .